This trial is active, not recruiting.

Condition ureteral obstruction
Treatment registry and database
Sponsor Indiana Kidney Stone Institute
Start date July 2003
End date December 2016
Trial size 64 participants
Trial identifier NCT00169650, 03-048


The gold standard for the treatment of ureteropelvic junction obstruction (UPJO) is the open pyeloplasty. As a minimally invasive alternative, many centers are currently offering laparoscopic pyeloplasty (LP) as primary therapy for UPJOs. Recent data has shown that laparoscopic pyeloplasty has comparable success rates to open pyeloplasties and produces durable results. The researchers are compiling a registry and database to review outcomes of laparoscopic pyeloplasty patients.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective retrospective
Registry and database of subjects undergoing laparoscopic pyeloplasty for ureteropelvic junction obstruction
registry and database
Subjects undergoing laparoscopic pyeloplasty for ureteropelvic junction obstruction at Methodist Urology in Indiana will be asked to participate in a registry and database to review outcomes of the surgery.

Primary Outcomes

To record and review the surgical outcomes of our population of UPJO patients who have been treated with LP. Once all retrospective data has been reviewed, we will continue to collect outcome data on a prospective basis
time frame: One year

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Male or female patients of Methodist Urology in Indianapolis, IN over the age of 18 with ureteropelvic junction obstruction Exclusion Criteria: - Patients unable to give informed consent - Patients with active bleeding diatheses - Women who are pregnant or in whom pregnancy status cannot be confirmed - Patients with medical conditions precluding laparoscopy - Patients with active urinary tract infection

Additional Information

Official title Laparoscopic Pyeloplasty: A Registry and Database
Principal investigator James E Lingeman, MD
Trial information was received from ClinicalTrials.gov and was last updated in February 2016.
Information provided to ClinicalTrials.gov by Indiana Kidney Stone Institute.